z-logo
open-access-imgOpen Access
Antiproliferative Bufadienolides from the Bulbs of Drimia altissima
Author(s) -
Linda C. Langat,
Moses K. Langat,
Wolfgang Wetschnig,
Walter Knirsch,
Dulcie A. Mulholland
Publication year - 2021
Publication title -
journal of natural products
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.976
H-Index - 139
eISSN - 1520-6025
pISSN - 0163-3864
DOI - 10.1021/acs.jnatprod.0c01079
Subject(s) - asparagaceae , pharmacognosy , cancer cell lines , stereochemistry , biology , chemistry , traditional medicine , botany , in vitro , biological activity , cancer cell , cancer , biochemistry , medicine , genetics
The bulbs of the South African Drimia altissima (Asparagaceae or Hyacinthaceae sensu APGII) have yielded a range of previously undescribed bufadienolides, drimianins A-G ( 1 - 7 ), the known bufadienolides bovogenin A ( 8 ), 3β- O- β-d - glucopyranosylbovogenin A ( 9 ), scillaren F ( 10 ), and altoside ( 11 ), the known homoisoflavonoid (3 S ) - 3-(4'-methoxybenzyl)-5,6,7-trimethoxychroman-4-one (urgineanin C), the sesquiterpenoids 1β,6α-dihydroxy-4(15)-eudesmene and 6α-hydroxy-4(15)-eudesmen-1-one, polybotrin, adenosine, and 9 R -hydroxy-(10 E ,12 Z )-octadecadienoic acid ethyl ester. The bufadienolides isolated were tested at 10 μM in the NCI-60 cancer cell screen, and nine of these were selected for further screening at five concentrations. Drimianins C ( 3 ) and E ( 5 ) showed activity at the nanomolar level against a number of human cancer cell lines in the NCI-60 screen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom